Michael A. Morse, MD

Professor of Medicine
Duke University Medical Center, United States

Presentation(s):

• 52: Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage.

  Saturday, March 25, 2023
  10:56 AM – 11:06 AM

  Disclosure information not submitted.